Guidance Document for Industry - Review of Drug Brand Names (French, HTML)

View metadata and access the original French HTML file: Guidance Document for Industry - Review of Drug Brand Names.

Format

HTML

Access

file-only

Publisher-reported update

2021-07-07

To provide market authorization holders direction on the process to be followed and information to be submitted to Health Canada regarding the potential for a proposed name to be misleading or confused with another product authorized for use in Canada with the aim of preventing medication errors.

Access original file